Statins meditate anti-atherosclerotic action in smooth muscle cells by peroxisome proliferator-activated receptor-γ activation-Reference-Cited by-同舟云学术

Statins meditate anti-atherosclerotic action in smooth muscle cells by peroxisome proliferator-activated receptor-γ activation

Published:2015-01 Issue:1 Volume:457 Page:23-30
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Fukuda Kazuki,Matsumura Takeshi,Senokuchi Takafumi,Ishii Norio,Kinoshita Hiroyuki,Yamada Sarie,Murakami Saiko,Nakao Saya,Motoshima Hiroyuki,Kondo Tatsuya,Kukidome Daisuke,Kawasaki Shuji,Kawada Teruo,Nishikawa Takeshi,Araki Eiichi

Funder

Grants-in-Aid for Scientific Research

20390259

Takeda Science Foundation

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference35 articles.

1. The evolving role of statins in the management of atherosclerosis;Vaughan;J. Am. Coll. Cardiol.,2000

2. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors;Takemoto;Arterioscler. Thromb. Vasc. Biol.,2001

3. Antiatherothrombotic properties of statins: implications for cardiovascular event reduction;Rosenson;JAMA,1998

4. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors;Laufs;Circulation,1998

5. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia;Weber;J. Am. Coll. Cardiol.,1997

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Methylglyoxal in Cardiometabolic Disorders: Routes Leading to Pathology Counterbalanced by Treatment Strategies;Molecules;2023-11-24

2. HMG-CoA Reductase Inhibitors Suppress Monosodium Urate-Induced NLRP3 Inflammasome Activation through Peroxisome Proliferator-Activated Receptor-γ Activation in THP-1 Cells;Pharmaceuticals;2023-03-31

3. Statins and COVID-19 (Mechanism of Action, Effect on Prognosis);Contemporary Cardiology;2022

4. Approaches for modifying cellular cholesterol levels and their application to mechanistic studies: Examples from the ion channel field;Cholesterol;2022

5. Control and monitoring of lipoprotein levels in atherosclerosis induced rabbits using novel nanoparticulate medication of Lovastatin and Rosuvastatin;Micro & Nano Letters;2021-05-19